serves as our special advisor. Mr. Margolis joined Oppenheimer & Co. Inc. in
2017 and serves as senior managing director and head of life sciences investment banking. Michael also serves as
co-head of healthcare investment banking. He has over two decades of investment banking experience in the life
sciences sectors. Prior to joining Oppenheimer, he served as the head of healthcare investment banking at Roth
Capital Partners, LLC and as a managing director at Merriman Holdings, Inc. (also known as Merriman Curhan Ford Group Inc.) Before becoming an investment banker, Michael worked at Novartis Pharmaceuticals Corporation in several roles, including as a director in the Global Business Development and Licensing group. He also served as an equity research analyst at Ursus Capital. He began his career at Eli Lilly & Company as a senior pharmaceutical representative. Michael is a registered pharmacist and holds an MBA from New York University’s Stern School of Business and a BS from Rutgers University, College of Pharmacy.